Dr. Bachier Discusses CAR T-Cell Therapy and Stem Cell Transplant – OncLive
|
Dr. Bachier Discusses CAR T-Cell Therapy and Stem Cell Transplant
OncLive Carlos R. Bachier, MD, program director of Sarah Cannon Center for Blood Cancer, Sarah Cannon Research Institute, discusses the relationship between chimeric antigen receptor (CAR) T-cell therapy and stem cell transplant. The excitement with CAR T-cell … |
